Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q1 2017 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2017-05-12

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 12, 2017

Total Value: $177M (92.5% shares, 7.5% debt)

Holdings (21)

— Recro Pharma, Inc. 14.2%

Value $25.12M Shares 2,874,317 Est. Cost $8.20 Unrealized —

— Viveve Medical, Inc 13.7%

Value $24.26M Shares 3,849,711 Est. Cost $6.92 Unrealized —

— Novelion Therapeutics, Inc. 9.4%

Value $16.76M Shares 1,560,487 Est. Cost $8.47 Unrealized —

— Sciclone Pharmaceuticals, Inc. 9.2%

Value $16.3M Shares 1,663,281 Est. Cost $10.55 Unrealized —

— Aegerion Pharmaceuticals, Inc. 7.5%

Value $13.28M Shares 16,600,000 Est. Cost $0.60 Unrealized —

— Ophthotech Corp 7.3%

Value $12.87M Shares 3,516,489 Est. Cost $4.42 Unrealized —

— Alere Inc. 6.2%

Value $10.93M Shares 275,000 Est. Cost $42.05 Unrealized —

VCEL Vericel Corp 5.2%

Value $9.143M Shares 3,265,323 Est. Cost $2.65 Unrealized +6.6%

— Cardiome Pharma Corp 4.7%

Value $8.299M Shares 2,757,260 Est. Cost $2.98 Unrealized —

— Avadel Pharmaceuticals PLC 4.1%

Value $7.283M Shares 752,410 Est. Cost $9.68 Unrealized —

ENTA Enanta Pharmaceuticals 3.2%

Value $5.701M Shares 185,099 Est. Cost $28.66 Unrealized +8.6%

— Biodelivery Sciences INTL 3.0%

Value $5.405M Shares 2,844,820 Est. Cost $1.76 Unrealized —

VCYT Veracyte, Inc. 3.0%

Value $5.308M Shares 578,200 Est. Cost $7.48 Unrealized +9.4%

CPIX Cumberland Pharmaceuticals, Inc. 2.9%

Value $5.135M Shares 739,917 Est. Cost $5.11 Unrealized +18.6%

— Alimera Sciences, Inc 2.0%

Value $3.607M Shares 2,576,273 Est. Cost $1.25 Unrealized —

— Durect Corporation 1.7%

Value $2.941M Shares 2,801,376 Est. Cost $1.30 Unrealized —

— Trinity Biotech PLC - SPON ADR 1.2%

Value $2.097M Shares 351,917 Est. Cost $6.92 Unrealized —

EBS Emergent Biosolutions Inc 0.9%

Value $1.583M Shares 54,505 Est. Cost $30.44 Unrealized 0.0%

XOMA XOMA CORP 0.4%

Value $625K Shares 87,960 Est. Cost $5.14 Unrealized 0.0%

VNDA VANDA PHARMACEUTICALS INC 0.3%

Value $606K Shares 43,300 Est. Cost $14.25 Unrealized 0.0%

— Aviragen Therapeutics, Inc. 0.1%

Value $205K Shares 314,421 Est. Cost $1.47 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Recro Pharma, Inc.	2,874,317	$25.12M	14.2%	$8.20	—	COM	75629F109
—	Viveve Medical, Inc	3,849,711	$24.26M	13.7%	$6.92	—	COM	92852W204
—	Novelion Therapeutics, Inc.	1,560,487	$16.76M	9.4%	$8.47	—	COM	67001K202
—	Sciclone Pharmaceuticals, Inc.	1,663,281	$16.3M	9.2%	$10.55	—	COM	80862K104
—	Aegerion Pharmaceuticals, Inc.	16,600,000	$13.28M	7.5%	$0.60	—	NOTE	00767EAB8
—	Ophthotech Corp	3,516,489	$12.87M	7.3%	$4.42	—	COM	683745103
—	Alere Inc.	275,000	$10.93M	6.2%	$42.05	—	COM	01449J105
VCEL	Vericel Corp	3,265,323	$9.143M	5.2%	$2.65	+6.6%	COM	92346J108
—	Cardiome Pharma Corp	2,757,260	$8.299M	4.7%	$2.98	—	COM	14159U301
—	Avadel Pharmaceuticals PLC	752,410	$7.283M	4.1%	$9.68	—	SPONS ADR	05337M104
ENTA	Enanta Pharmaceuticals	185,099	$5.701M	3.2%	$28.66	+8.6%	COM	29251M106
—	Biodelivery Sciences INTL	2,844,820	$5.405M	3.0%	$1.76	—	COM	09060J106
VCYT	Veracyte, Inc.	578,200	$5.308M	3.0%	$7.48	+9.4%	COM	92337F107
CPIX	Cumberland Pharmaceuticals, Inc.	739,917	$5.135M	2.9%	$5.11	+18.6%	COM	230770109
—	Alimera Sciences, Inc	2,576,273	$3.607M	2.0%	$1.25	—	COM	016259103
—	Durect Corporation	2,801,376	$2.941M	1.7%	$1.30	—	COM	266605104
—	Trinity Biotech PLC - SPON ADR	351,917	$2.097M	1.2%	$6.92	—	SPONS ADR	896438306
EBS	Emergent Biosolutions Inc	54,505	$1.583M	0.9%	$30.44	0.0%	COM	29089Q105
XOMA	XOMA CORP	87,960	$625K	0.4%	$5.14	0.0%	COM	98419J206
VNDA	VANDA PHARMACEUTICALS INC	43,300	$606K	0.3%	$14.25	0.0%	COM	921659108
—	Aviragen Therapeutics, Inc.	314,421	$205K	0.1%	$1.47	—	COM	053761102